Increasing Prevalence And Incidence Of Chronic Disorder Is Escalating The Growth Of The Fibromyalgia Treatment Market

Fibromyalgia Treatment


 Fibromyalgia causes widespread fatigue, widespread pain, and various other kinds of discomforts. Symptoms closely resemble those of fibromyalgia, yet fibromyalgia usually affects only the soft tissue, never the joints. The exact cause is still unknown, but possible risk factors include trauma, rheumatoid disease, and various autoimmune diseases, including Lupus and multiple sclerosis. Fibromyalgia is also frequently associated with neurologic disorders and psychiatric diseases. Some of these conditions include depression, psychosis, post-traumatic stress disorder, delusional parasitosis, bulimia, anorexia nervosa, eating disorders, and drug abuse.

The increasing prevalence of accidents around the globe is leading to chronic pain. This is creating demand for pain relieving drugs, thereby fueling the growth of the fibromyalgia treatment market. According to the National Center for Health Statistics, overall, the prevalence of chronic pain was 20.4%, and the prevalence of high-impact chronic pain was 7.4% (or 36.4% of adults who had chronic pain). Chronic pain was highest among women (21.7%), non-Hispanic white adults (23.6%), and those aged 65 and over (30.8%). Moreover, the growing prevalence of rheumatic diseases coupled with the increase in the geriatric population is further anticipated to foster the growth of the fibromyalgia market over the forecast period.

North America is expected to gain significant growth over the forecast period and this is attributed to the high prevalence of the chronic disease in the region. According to the National Health Council, chronic diseases affect around 133 million Americans, representing more than 40% of the total population of this country. By 2020, that number is projected to grow to an estimated 157 million, with 81 million having multiple conditions.

Key Developments:

1.      In September 2017, AVACEN Medical (AVACEN) has partnered with Morulaa HealthTech of Chennai, India, to launch its U.S. Food and Drug Administration-cleared and CE Marked AVACEN 100, Class II medical device, in the country for treating the widespread pain associated with fibromyalgia.

2.      In October 2020, Fibro Solution, a health company founded by award-winning fibromyalgia experts has launched its Fibro Warriors Program to help people suffering from fibromyalgia get their lives back without the use of harmful pills or side effects.

3.      In December 2020, Tonix Pharmaceuticals Holding Corp. a clinical-stage biopharmaceutical company announced that TNX-102 SL (cyclobenzaprine HCl sublingual tablets) met its pre-specified primary endpoint, significantly reducing daily pain compared to placebo (p=0.01) in participants with fibromyalgia in the Phase 3 RELIEF study. 

Comments

Post a Comment

Popular posts from this blog

Bourbon Whiskey Is the Most Popular Whiskey in America and In Many Other Countries around the World

Image
  Whiskey or single malt whiskey is simply a form of distilled beverage made by distilling alcohol from grain mash or even by blending both. Different grains are utilized for different types, such as corn, barley, rye, and wheat. In Scotland, they call their whiskey black tea, a lighter caramel scotch, Irish cream, and liqueur. Whichever form is utilized, the result is usually a flavorful and smooth drink that has a distinct taste, and many people prefer a whiskey with a lower alcohol content. For example, single malt whiskey is the least expensive. The highest price however is the least distilled; that is Bourbon whiskey. Bourbon whiskey is the most popular whiskey in America and in many other countries around the world. Its price range is very wide, starting from as low as about US$ 12 a bottle to over a hundred dollars. So the price definitely varies. Whichever class you belong to, there is always a whiskey that will suit your preference. Single malt scotch whiskey is made ...
Read more

Viral Vectors And Plasmid DNA Manufacturing Market Is Gaining Major Traction With Oxford Biomedica Plc Entering Into A 3-Year Agreement With Boehringer Ingelheim For The Manufacture And Supply Of Various Types Of Viral Vectors

Image
  Viral Vectors are proteins that have been discovered to be essential for the spread of various viruses and infectious agents. These proteins can cause serious health risks if they are improperly introduced or if a wrong agent is used to fight them off. Viral vectors have often been used in various gene therapy procedures with the ultimate objective of curing various ailments in the biological fields of neurology, gene therapy, cancer, and metabolic disorder. Clinical studies regarding viral vectors remain one of the key factors in the manufacturing of viral vectors. Plasmids are used to deliver DNA contain genes for antibiotic resistance. In fact, scientists have developed many uses of plasmids and created software to record the DNA sequences of plasmids for applications in various techniques. Thus, such continuous R&D activities can potentially stimulate growth of the viral vectors and plasmid DNA manufacturing market . Recently, in April 2021, Oxford Biomedica plc entered...
Read more

Hard Surface Flooring Market Is Expected To Witness Robust Growth As Mohawk Industries Introduces Newly Imagined 30,000-Square Foot Floor Space At The International Surface Event (TISE)

Image
  There are many reasons why people choose hard surface floors over other types of flooring. Hard surfaces offer a level of durability and are very aesthetically pleasing. Unfortunately, choosing this type of flooring can be confusing and costly. There are four main hard surface varieties namely vinyl plank, laminate, solid hardwood, and engineered wood. Each has their own style strengths and provide different advantages. Increasing population coupled with rapid urbanization is expected to drive growth of the global hard surface flooring market . According to the United Nations (UN), by 2050, around 68% of the global population is expected to live in urban areas, increasing from 55% in 2018. According to the same source, in 2018, around 4.2 billion people were living in urban areas, increasing from 751 million in 1950. Furthermore, according to the World Bank, in 2019, the global population reached 7.674 billion, increasing from 6.84 billion in 2009. As a result of this, building...
Read more